EcoDrugPlus

Aurora Kinase B-Like

Ensembl ID : ENSSDUG00000003445
Gene Symbol: LOC111232562
3 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSSDUG00000012384
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSDUG00000010755
Gene Symbol: BDKRB2
3 Cross references
155 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSDUG00000015531
Gene Symbol: BDKRB2
3 Cross references
248 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSDUG00000015518
Gene Symbol: BDKRB2
3 Cross references
248 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSSDUG00000015560
Gene Symbol: BDKRB2
4 Cross references
167 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSSDUG00000004015
Gene Symbol: LOC111226561
3 Cross references
196 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSSDUG00000007357
Gene Symbol: LOC111228756
2 Cross references
224 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSSDUG00000004627
Gene Symbol: CACNA1C
1 Cross references
212 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSSDUG00000004473
Gene Symbol: CACNA1C
1 Cross references
212 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSSDUG00000006989
Gene Symbol: CASR
3 Cross references
202 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSSDUG00000013963
Gene Symbol: CACNA2D1
4 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).